{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:40Z","timestamp":1792783120609,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Research Projects Unit of Ordu University","award":["A2320"],"award-info":[{"award-number":["A2320"]}],"id":[{"id":"https:\/\/ror.org\/04r0hn449","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12811-w","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:00:47Z","timestamp":1790168447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro evaluation of the Anticarcinogenic effects of zerumbone in the SK-UT-1 human uterine Leiomyosarcoma cell line"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9957-5485","authenticated-orcid":false,"given":"Sumeyya Deniz","family":"Aybek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2084-760X","authenticated-orcid":false,"given":"Mucahit","family":"Secme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5201-6352","authenticated-orcid":false,"given":"Gonca","family":"Gulbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"12811_CR1","doi-asserted-by":"publisher","unstructured":"Bose S, Schwartz GK, Ingham M (2022) Novel Therapeutics in the Treatment of Uterine Sarcoma. Am Soc Clin Oncol Educ Book 900\u2013909. https:\/\/doi.org\/10.1200\/EDBK_350541","DOI":"10.1200\/EDBK_350541"},{"key":"12811_CR2","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/cells13131106","volume":"13","author":"Q Yang","year":"2024","unstructured":"Yang Q, Madueke-Laveaux OS, Cun H, Wlodarczyk M, Garcia N, Carvalho KC, Al-Hendy A (2024) Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy. Cells 13:1106. https:\/\/doi.org\/10.3390\/cells13131106","journal-title":"Cells"},{"key":"12811_CR3","doi-asserted-by":"publisher","first-page":"106693","DOI":"10.1016\/j.phrs.2023.106693","volume":"189","author":"Y Nagao","year":"2023","unstructured":"Nagao Y, Yokoi A, Yoshida K, Sugiyama M, Watanabe E, Nakamura K, Kitagawa M, Asano-Inami E, Koya Y, Yoshihara M, Tamauchi S, Shimizu Y, Ikeda Y, Yoshikawa N, Kato T, Yamamoto Y, Kajiyama H (2023) Novel therapeutic strategies targeting UCP2 in uterine leiomyosarcoma. Pharmacol Res 189:106693. https:\/\/doi.org\/10.1016\/j.phrs.2023.106693","journal-title":"Pharmacol Res"},{"key":"12811_CR4","doi-asserted-by":"publisher","unstructured":"Meng Y, Yang Y, Zhang Y, Li X (2020) Construction and Validation of Nomograms for Predicting the Prognosis of Uterine Leiomyosarcoma: A Population-Based Study. Med Sci Monit 26. https:\/\/doi.org\/10.12659\/MSM.922739","DOI":"10.12659\/MSM.922739"},{"key":"12811_CR5","unstructured":"Network NCC (2025) Treatment by Cancer Type. In: NCCN. https:\/\/www.nccn.org\/guidelines\/category_1. Accessed 31 Oct 2025"},{"key":"12811_CR6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1021\/acs.jafc.7b04472","volume":"66","author":"T Sithara","year":"2018","unstructured":"Sithara T, Dhanya BP, Arun KB, Sini S, Dan M, Kokkuvayil Vasu R, Nisha P (2018) Zerumbone, a Cyclic Sesquiterpene from Zingiber zerumbet Induces Apoptosis, Cell Cycle Arrest, and Antimigratory Effects in SW480 Colorectal Cancer Cells. J Agric Food Chem 66:602\u2013612. https:\/\/doi.org\/10.1021\/acs.jafc.7b04472","journal-title":"J Agric Food Chem"},{"key":"12811_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ygyno.2011.03.001","volume":"122","author":"TF Wong","year":"2011","unstructured":"Wong TF, Takeda T, Li B, Tsuiji K, Kitamura M, Kondo A, Yaegashi N (2011) Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition. Gynecol Oncol 122:141\u2013148. https:\/\/doi.org\/10.1016\/j.ygyno.2011.03.001","journal-title":"Gynecol Oncol"},{"key":"12811_CR8","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.3390\/nu15112557","volume":"15","author":"S Greco","year":"2023","unstructured":"Greco S, Pellegrino P, Giampieri F, Capocasa F, Delli Carpini G, Battino M, Mezzetti B, Giannubilo SR, Ciavattini A, Ciarmela P (2023) The In Vitro Effects of Romina Strawberry Extract on 3D Uterine Leiomyosarcoma Cells. Nutrients 15:2557. https:\/\/doi.org\/10.3390\/nu15112557","journal-title":"Nutrients"},{"key":"12811_CR9","doi-asserted-by":"publisher","first-page":"637024","DOI":"10.3389\/fonc.2021.637024","volume":"11","author":"C Wei","year":"2021","unstructured":"Wei C, Li D, Liu Y, Wang W, Qiu T (2021) Curdione Induces Antiproliferation Effect on Human Uterine Leiomyosarcoma via Targeting IDO1. Front Oncol 11:637024. https:\/\/doi.org\/10.3389\/fonc.2021.637024","journal-title":"Front Oncol"},{"key":"12811_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12032-024-02327-3","volume":"41","author":"A Soroush","year":"2024","unstructured":"Soroush A, Pourhossein S, Hosseingholizadeh D, Hjazi A, Shahhosseini R, Kavoosi H, Kermanshahi N, Behnamrad P, Ghavamikia N, Dadashpour M, Karkon Shayan S (2024) Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives. Med Oncol 41:125. https:\/\/doi.org\/10.1007\/s12032-024-02327-3","journal-title":"Med Oncol"},{"key":"12811_CR11","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.3390\/molecules30142936","volume":"30","author":"SD Aybek","year":"2025","unstructured":"Aybek SD, Secme M, Ilhan H, Acik L, Celik SP, Gulbay G (2025) Multifaceted Applications of Zerumbone-Loaded Metal\u2013Organic Framework-5: Anticancer, Antibacterial, Antifungal, DNA-Binding, and Free Radical Scavenging Potentials. Molecules 30:2936. https:\/\/doi.org\/10.3390\/molecules30142936","journal-title":"Molecules"},{"key":"12811_CR12","doi-asserted-by":"publisher","first-page":"652860","DOI":"10.3389\/fphar.2021.652860","volume":"12","author":"C-C Su","year":"2021","unstructured":"Su C-C, Wang S-C, Chen I-C, Chiu F-Y, Liu P-L, Huang C-H, Huang K-H, Fang S-H, Cheng W-C, Huang S-P, Yeh H-C, Liu C-C, Lee P-Y, Huang M-Y, Li C-Y (2021) Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages. Front Pharmacol 12:652860. https:\/\/doi.org\/10.3389\/fphar.2021.652860","journal-title":"Front Pharmacol"},{"key":"12811_CR13","doi-asserted-by":"publisher","unstructured":"Hemn HO, Noordin M, Hazilawati H, Zuki A, Chartrand M (2015) Antihypercholesterolemic and antioxidant efficacies of zerumbone on the formation, development, and establishment of atherosclerosis in cholesterol-fed rabbits. Drug Des Devel Ther 4173. https:\/\/doi.org\/10.2147\/DDDT.S76225","DOI":"10.2147\/DDDT.S76225"},{"key":"12811_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3923\/pjbs.2018.475.479","volume":"21","author":"A Sf","year":"2018","unstructured":"Sf A, Maharjan R (2018) Immunomodulation of Zerumbone via Decreasing the Production of Reactive Oxygen Species from Immune Cells. Pak J Biol Sci PJBS 21:475\u2013479","journal-title":"Pak J Biol Sci PJBS"},{"key":"12811_CR15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/01635581.2016.1159701","volume":"68","author":"SD Jegannathan","year":"2016","unstructured":"Jegannathan SD, Arul S, Dayalan H (2016) Zerumbone, a Sesquiterpene, Controls Proliferation and Induces Cell Cycle Arrest in Human Laryngeal Carcinoma Cell Line Hep-2. Nutr Cancer 68:865\u2013872. https:\/\/doi.org\/10.1080\/01635581.2016.1159701","journal-title":"Nutr Cancer"},{"key":"12811_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/10915818221104417","volume":"41","author":"F Memari","year":"2022","unstructured":"Memari F, Mirzavi F, Jalili-Nik M, Afshari AR, Ghorbani A, Soukhtanloo M (2022) Tumor-Inhibitory Effects of Zerumbone Against HT-29 Human Colorectal Cancer Cells. Int J Toxicol 41:402\u2013411. https:\/\/doi.org\/10.1177\/10915818221104417","journal-title":"Int J Toxicol"},{"key":"12811_CR17","doi-asserted-by":"publisher","first-page":"8479","DOI":"10.1007\/s13277-015-3583-z","volume":"36","author":"I Rajan","year":"2015","unstructured":"Rajan I, Jayasree PR, Kumar PRM (2015) Zerumbone induces mitochondria-mediated apoptosis via increased calcium, generation of reactive oxygen species and upregulation of soluble histone H2AX in K562 chronic myelogenous leukemia cells. Tumor Biol 36:8479\u20138489. https:\/\/doi.org\/10.1007\/s13277-015-3583-z","journal-title":"Tumor Biol"},{"key":"12811_CR18","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1158\/0008-5472.CAN-09-1161","volume":"69","author":"S Yodkeeree","year":"2009","unstructured":"Yodkeeree S, Sung B, Limtrakul P, Aggarwal BB (2009) Zerumbone Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors in Human Colon Cancer Cells: Evidence for an Essential Role of Reactive Oxygen Species. Cancer Res 69:6581\u20136589. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1161","journal-title":"Cancer Res"},{"key":"12811_CR19","doi-asserted-by":"publisher","unstructured":"Barathan Muttiah, Vellasamy KM, Ibrahim Z, Mariappan V, Hoong S, Vadievlu J (2021) Zerumbone mediates apoptosis and induces secretion of proinflammatory cytokines in breast carcinoma cell culture. Iran J Basic Med Sci 24. https:\/\/doi.org\/10.22038\/ijbms.2021.58573.13012","DOI":"10.22038\/ijbms.2021.58573.13012"},{"key":"12811_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1349-7006.2006.00362.x","volume":"98","author":"M Xian","year":"2007","unstructured":"Xian M, Ito K, Nakazato T, Shimizu T, Chen C, Yamato K, Murakami A, Ohigashi H, Ikeda Y, Kizaki M (2007) Zerumbone, a bioactive sesquiterpene, induces G2\/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria\u2010mediated pathway. Cancer Sci 98:118\u2013126. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00362.x","journal-title":"Cancer Sci"},{"key":"12811_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-012-2280-5","volume":"136","author":"A Sehrawat","year":"2012","unstructured":"Sehrawat A, Arlotti JA, Murakami A, Singh SV (2012) Zerumbone causes Bax- and Bak-mediated apoptosis in human breast cancer cells and inhibits orthotopic xenograft growth in vivo. Breast Cancer Res Treat 136:429\u2013441. https:\/\/doi.org\/10.1007\/s10549-012-2280-5","journal-title":"Breast Cancer Res Treat"},{"key":"12811_CR22","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.intimp.2012.01.014","volume":"12","author":"SI Abdelwahab","year":"2012","unstructured":"Abdelwahab SI, Abdul AB, Zain ZNM, Hadi AHA (2012) Zerumbone inhibits interleukin-6 and induces apoptosis and cell cycle arrest in ovarian and cervical cancer cells. Int Immunopharmacol 12:594\u2013602. https:\/\/doi.org\/10.1016\/j.intimp.2012.01.014","journal-title":"Int Immunopharmacol"},{"key":"12811_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12672-025-02253-4","volume":"16","author":"S Nobari","year":"2025","unstructured":"Nobari S, Shojaeian A, Jalilian FA, Kalvandi G, Amini R (2025) Modulation of the tumor microenvironment by zerumbone and 5-fluorouracil in colorectal cancer by target in cancer-associated fibroblasts. Discov Oncol 16:505. https:\/\/doi.org\/10.1007\/s12672-025-02253-4","journal-title":"Discov Oncol"},{"key":"12811_CR24","first-page":"S731","volume":"13","author":"NA Samad","year":"2018","unstructured":"Samad NA, Abdul AB, Rahman HS, Rasedee A, Ibrahim TAT, Keon YS (2018) Zerumbone suppresses angiogenesis in HepG2 cells through inhibition of matrix metalloproteinase-9, vascular endothelial growth factor, and vascular endothelial growth factor receptor expressions. Pharmacogn Mag 13:S731","journal-title":"Pharmacogn Mag"},{"key":"12811_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.biochi.2014.09.001","volume":"107","author":"Z Hu","year":"2014","unstructured":"Hu Z, Zeng Q, Zhang B, Liu H, Wang W (2014) Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells. Biochimie 107:257\u2013262. https:\/\/doi.org\/10.1016\/j.biochi.2014.09.001","journal-title":"Biochimie"},{"key":"12811_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/9369328","volume":"2022","author":"S Nobari","year":"2022","unstructured":"Nobari S, Najafi R, Mahdavinezhad A, Jalali A, Amini R (2022) The Combination of Zerumbone with 5-Fluorouracil for Sensitizing Colorectal Cancer-Associated Fibroblasts to Treatment. Evid Based Complement Alternat Med 2022:1\u201313. https:\/\/doi.org\/10.1155\/2022\/9369328","journal-title":"Evid Based Complement Alternat Med"},{"key":"12811_CR27","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.2174\/1871520622666220324090801","volume":"22","author":"SD Jegannathan","year":"2022","unstructured":"Jegannathan SD, Arul S, Dayalan H (2022) Zerumbone Sensitizes the Anti-Cancer Efficacy of Cisplatin in HepatocellularCarcinoma Cells. Anticancer Agents Med Chem 22:2885\u20132895. https:\/\/doi.org\/10.2174\/1871520622666220324090801","journal-title":"Anticancer Agents Med Chem"},{"key":"12811_CR28","first-page":"4103","volume":"6","author":"M Greenwell","year":"2015","unstructured":"Greenwell M, Rahman P (2015) Medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res 6:4103","journal-title":"Int J Pharm Sci Res"},{"key":"12811_CR29","first-page":"202","volume":"8","author":"G Butt","year":"2014","unstructured":"Butt G, Hussain E, Rehman A (2014) Ferrous ion-chelating Assay for analysis of antioxidant potential of Sargassum sp and Iyengaria sp. Pak J Med Health Sci 8:202\u2013203","journal-title":"Pak J Med Health Sci"},{"key":"12811_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.phymed.2017.12.011","volume":"39","author":"NS Zainal","year":"2018","unstructured":"Zainal NS, Gan CP, Lau BF, Yee PS, Tiong KH, Abdul Rahman ZA, Patel V, Cheong SC (2018) Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells. Phytomedicine 39:33\u201341. https:\/\/doi.org\/10.1016\/j.phymed.2017.12.011","journal-title":"Phytomedicine"},{"key":"12811_CR31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/biof.1756","volume":"47","author":"M Jalili-Nik","year":"2021","unstructured":"Jalili-Nik M, Afshari AR, Sabri H, Bibak B, Mollazadeh H, Sahebkar A (2021) Zerumbone, a ginger sesquiterpene, inhibits migration, invasion, and metastatic behavior of human malignant glioblastoma multiforme in vitro. BioFactors 47:729\u2013739. https:\/\/doi.org\/10.1002\/biof.1756","journal-title":"BioFactors"},{"key":"12811_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/3237983","volume":"2020","author":"M Jalili-Nik","year":"2020","unstructured":"Jalili-Nik M, Sadeghi MM, Mohtashami E, Mollazadeh H, Afshari AR, Sahebkar A (2020) Zerumbone Promotes Cytotoxicity in Human Malignant Glioblastoma Cells through Reactive Oxygen Species (ROS) Generation. Oxid Med Cell Longev 2020:1\u20139. https:\/\/doi.org\/10.1155\/2020\/3237983","journal-title":"Oxid Med Cell Longev"},{"key":"12811_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s10637-021-01190-7","volume":"40","author":"J Schnoell","year":"2022","unstructured":"Schnoell J, Stanisz I, Jank BJ, Stanek V, Schmid R, Brunner M, Heiduschka G, Kotowski U (2022) Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma. Invest New Drugs 40:224\u2013231. https:\/\/doi.org\/10.1007\/s10637-021-01190-7","journal-title":"Invest New Drugs"},{"key":"12811_CR34","doi-asserted-by":"crossref","unstructured":"Crespo M, Ross ME (2013) Cell Cycle Regulation in Brain Construction. In: Rubenstein JLR, Rakic P (ed) Patterning and Cell Type Specification in the Developing CNS and PNS. Elsevier, pp 285\u2013301","DOI":"10.1016\/B978-0-12-397265-1.00094-0"},{"key":"12811_CR35","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.1158\/1078-0432.CCR-03-0751","volume":"10","author":"A Bali","year":"2004","unstructured":"Bali A, O\u2019Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM (2004) Cyclin D1, p53, and p21Waf1\/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian Cancer. Clin Cancer Res 10:5168\u20135177. https:\/\/doi.org\/10.1158\/1078-0432.CCR-03-0751","journal-title":"Clin Cancer Res"},{"key":"12811_CR36","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41598-018-37553-z","volume":"9","author":"X Yang","year":"2019","unstructured":"Yang X, Zhao L, Zhang T, Xi J, Liu S, Ren L, Zheng Y, Zhang H (2019) Protosappanin B promotes apoptosis and causes G1 cell cycle arrest in human bladder cancer cells. Sci Rep 9:1048. https:\/\/doi.org\/10.1038\/s41598-018-37553-z","journal-title":"Sci Rep"},{"key":"12811_CR37","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.molcel.2019.03.020","volume":"74","author":"BR Topacio","year":"2019","unstructured":"Topacio BR, Zatulovskiy E, Cristea S, Xie S, Tambo CS, Rubin SM, Sage J, K\u00f5ivom\u00e4gi M, Skotheim JM (2019) Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein\u2019s C-Terminal Helix. Mol Cell 74:758\u2013770e4. https:\/\/doi.org\/10.1016\/j.molcel.2019.03.020","journal-title":"Mol Cell"},{"key":"12811_CR38","doi-asserted-by":"publisher","first-page":"151318","DOI":"10.1016\/j.ejcb.2023.151318","volume":"102","author":"M Mortoglou","year":"2023","unstructured":"Mortoglou M, Miralles F, Mould RR, Sengupta D, Uysal-Onganer P (2023) Inhibiting CDK4\/6 in pancreatic ductal adenocarcinoma via microRNA-21. Eur J Cell Biol 102:151318. https:\/\/doi.org\/10.1016\/j.ejcb.2023.151318","journal-title":"Eur J Cell Biol"},{"key":"12811_CR39","volume-title":"Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma","author":"P Ragazzini","year":"2004","unstructured":"Ragazzini P, Gamberi G, Pazzaglia L, Serra M, Magagnoli G, Ponticelli F, Ferrari C, Ghinelli C, Alberghini M, Bertoni F (2004) Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol Histopathol"},{"key":"12811_CR40","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1535-7163.MCT-17-0040","volume":"16","author":"AM Francis","year":"2017","unstructured":"Francis AM, Alexander A, Liu Y, Vijayaraghavan S, Low KH, Yang D, Bui T, Somaiah N, Ravi V, Keyomarsi K, Hunt KK (2017) CDK4\/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest. Mol Cancer Ther 16:1751\u20131764. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0040","journal-title":"Mol Cancer Ther"},{"key":"12811_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3914232","volume":"2019","author":"MJ B\u00f6hm","year":"2019","unstructured":"B\u00f6hm MJ, Marienfeld R, J\u00e4ger D, Mellert K, Von Witzleben A, Br\u00fcderlein S, Wittau M, Von Baer A, Schultheiss M, Mayer-Steinacker R, R\u00fccker FG, M\u00f6ller P, Bullinger L, Barth TFE (2019) Analysis of the CDK4\/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib. Sarcoma 2019:1\u201310. https:\/\/doi.org\/10.1155\/2019\/3914232","journal-title":"Sarcoma"},{"key":"12811_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/CAD.0000000000000171","volume":"26","author":"JE Jorvig","year":"2015","unstructured":"Jorvig JE, Chakraborty A (2015) Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2\/STAT3 pathway and increases paclitaxel sensitivity. Anticancer Drugs 26:160\u2013166. https:\/\/doi.org\/10.1097\/CAD.0000000000000171","journal-title":"Anticancer Drugs"},{"key":"12811_CR43","doi-asserted-by":"publisher","first-page":"7202","DOI":"10.1038\/s41598-024-57680-0","volume":"14","author":"SS Alghamdi","year":"2024","unstructured":"Alghamdi SS, Alghashem SA, Ali R, Alsubait A, Suliman RS, Mohammed AE, Alehaideb Z, Alshafi RA, Alturki AY, Rahman I (2024) Exploring the potential of Ziziphus nummularia and luteolin-7-O-glucoside as tubulin inhibitors in cancer therapy and survival. Sci Rep 14:7202. https:\/\/doi.org\/10.1038\/s41598-024-57680-0","journal-title":"Sci Rep"},{"key":"12811_CR44","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/cells13100863","volume":"13","author":"Y Li","year":"2024","unstructured":"Li Y, Rasheed M, Liu J, Chen Z, Deng Y (2024) Deciphering the Molecular Nexus: An In-Depth Review of Mitochondrial Pathways and Their Role in Cell Death Crosstalk. Cells 13:863. https:\/\/doi.org\/10.3390\/cells13100863","journal-title":"Cells"},{"key":"12811_CR45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ygyno.2005.09.055","volume":"101","author":"AL Leiser","year":"2006","unstructured":"Leiser AL, Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi DS, Soslow RA (2006) Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecol Oncol 101:86\u201391. https:\/\/doi.org\/10.1016\/j.ygyno.2005.09.055","journal-title":"Gynecol Oncol"},{"key":"12811_CR46","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/ced.12986","volume":"41","author":"SD Wang","year":"2016","unstructured":"Wang SD, Wang ZH, Yan HQ, Ren MY, Gao SQ, Zhang GQ (2016) Chemotherapeutic effect of Zerumbone on melanoma cells through mitochondria-mediated pathways. Clin Exp Dermatol 41:858\u2013863. https:\/\/doi.org\/10.1111\/ced.12986","journal-title":"Clin Exp Dermatol"},{"key":"12811_CR47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1423-0127-19-86","volume":"19","author":"HY Weng","year":"2012","unstructured":"Weng HY, Hsu MJ, Wang CC, Chen BC, Hong CY, Chen MC, Chiu WT, Lin CH (2012) Zerumbone suppresses IKK\u03b1, Akt, and FOXO1 activation, resulting in apoptosis of GBM 8401 cells. J Biomed Sci 19:86. https:\/\/doi.org\/10.1186\/1423-0127-19-86","journal-title":"J Biomed Sci"},{"key":"12811_CR48","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8335","author":"T Lv","year":"2018","unstructured":"Lv T, Zhang W, Han X (2018) Zerumbone suppresses the potential of growth and metastasis in hepatoma HepG2 cells via the MAPK signaling pathway. Oncol Lett. https:\/\/doi.org\/10.3892\/ol.2018.8335","journal-title":"Oncol Lett"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12811-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:00:52Z","timestamp":1790168452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12811-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12811"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12811-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since it is a cell culture study, it does not require ethics committee approval.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1617"}}